aivareta
sandoz d.d. - etinilestradiolis/drospirenonas - plėvele dengtos tabletės - 0,03 mg/3 mg - drospirenone and ethinylestradiol
ammily
orivas, uab - dienogestas/etinilestradiolis - plėvele dengtos tabletės - 2 mg/0,03 mg - dienogest and ethinylestradiol
cerazette
merck sharp & dohme b.v. - dezogestrelis - plėvele dengtos tabletės - 75 µg - desogestrel
flamica
inteli generics nord, uab - etinilestradiolis/drospirenonas - plėvele dengtos tabletės - 0,03 mg/3 mg; 0,02 mg/3 mg - drospirenone and ethinylestradiol
lindynette
gedeon richter plc - gestodenas/etinilestradiolis - dengtos tabletės - 75 µg/20 µg; 75 µg/30 µg - gestodene and ethinylestradiol
lisa
inteli generics nord, uab - dienogestas/etinilestradiolis - plėvele dengtos tabletės - 2 mg/0,03 mg - dienogest and ethinylestradiol
logest
bayer ag - gestodenas/etinilestradiolis - dengtos tabletės - 75 µg/20 µg - gestodene and ethinylestradiol
ongavia
actavis group ptc ehf. - etonogestrelis/etinilestradiolis - vartojimo į makštį sistema - 120 µg/15 µg/24 val. - vaginal ring with progestogen and estrogen
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantais, pasirinktinio imunosupresantais - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).